Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion type Assertion NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_head.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion description "[Partial inhibition of RLIP76 using antibodies in the absence of chemotherapy drug causes apoptosis in multiple small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) cell lines and in the presence of doxorubicin (DOX), marked synergy is observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_provenance.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion evidence source_evidence_literature NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_provenance.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion SIO_000772 15950949 NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_provenance.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion wasDerivedFrom befree-20150227 NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_provenance.
- NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_assertion wasGeneratedBy ECO_0000203 NP856296.RAG-5MYd_rvxUmXwmYGihjpt1dJeXseE6yzS-FfAQOJMQ130_provenance.